ArticleDisease markers2022

CDX2 as a Predictive Biomarker Involved in Immunotherapy Response Suppresses Metastasis through EMT in Colorectal Cancer.

Yun-Shuai Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.